Understanding the real-world healthcare resource utilization and costs of severe hemophilia A without inhibitors among adults treated with long-term prophylaxis in the United States by payer type
Author(s):
Sandra Santos, Jarren Santos, David Hinds, Jonathan Schwartz, Joshua Sammon, Ruthel Jarvis Goss, Nabil Daoud, Tammuella Chrisentery-Singleton
Publication:
Academy of Managed Care Pharmacy (ACMP) Nexus 2024
Date:
October 14-17, 2024
Topics:
hemophilia A, inhibitors, prophylaxis, ATHNdataset